Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach

The Clinical Trials Transformation Initiative convened with several groups in the pediatric antibacterial drug development community with the goal of identifying challenges and recommending ways to improve current practice. Attention to 5 major areas hold the promise of making new antibiotics availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Noel, Gary J, Nambiar, Sumathi, Bradley, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450364/
https://www.ncbi.nlm.nih.gov/pubmed/29438520
http://dx.doi.org/10.1093/jpids/piy001
_version_ 1783409014720167936
author Noel, Gary J
Nambiar, Sumathi
Bradley, John
author_facet Noel, Gary J
Nambiar, Sumathi
Bradley, John
author_sort Noel, Gary J
collection PubMed
description The Clinical Trials Transformation Initiative convened with several groups in the pediatric antibacterial drug development community with the goal of identifying challenges and recommending ways to improve current practice. Attention to 5 major areas hold the promise of making new antibiotics available for use in children as soon as possible after they are approved for use in adults.
format Online
Article
Text
id pubmed-6450364
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-64503642019-04-10 Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach Noel, Gary J Nambiar, Sumathi Bradley, John J Pediatric Infect Dis Soc Invited Review The Clinical Trials Transformation Initiative convened with several groups in the pediatric antibacterial drug development community with the goal of identifying challenges and recommending ways to improve current practice. Attention to 5 major areas hold the promise of making new antibiotics available for use in children as soon as possible after they are approved for use in adults. Oxford University Press 2018-02-08 /pmc/articles/PMC6450364/ /pubmed/29438520 http://dx.doi.org/10.1093/jpids/piy001 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Invited Review
Noel, Gary J
Nambiar, Sumathi
Bradley, John
Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
title Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
title_full Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
title_fullStr Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
title_full_unstemmed Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
title_short Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
title_sort advancing pediatric antibacterial drug development: a critical need to reinvent our approach
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450364/
https://www.ncbi.nlm.nih.gov/pubmed/29438520
http://dx.doi.org/10.1093/jpids/piy001
work_keys_str_mv AT noelgaryj advancingpediatricantibacterialdrugdevelopmentacriticalneedtoreinventourapproach
AT nambiarsumathi advancingpediatricantibacterialdrugdevelopmentacriticalneedtoreinventourapproach
AT bradleyjohn advancingpediatricantibacterialdrugdevelopmentacriticalneedtoreinventourapproach
AT advancingpediatricantibacterialdrugdevelopmentacriticalneedtoreinventourapproach

Ejemplares similares